Savara Inc. (SVRA) - Latest Market Data

Price & Market Data

Price: $5.08

Daily Change: -$0.04 / 0.79%

Daily Range: $4.85 - $5.24

Market Cap: $1,041,004,480

Daily Volume: 718,682

Performance Metrics

1 Week: -3.24%

1 Month: -14.19%

3 Months: -3.61%

6 Months: 28.61%

1 Year: 68.21%

YTD: -15.75%

About Savara Inc. (SVRA)

Discover the financial pulse of Savara Inc. (SVRA). Current price: 5.08, daily change: -$0.04 / 0.79%. Market cap: 1,041,004,480. Get YTD and 52-week performance.

Company Details

Employees: 70

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Selected stocks

Anixa Biosciences, Inc. (ANIX)

Federated Hermes Premier Municipal Income Fund (FMN)

Glacier Bancorp, Inc. (GBCI)

Bridgewater Bancshares, Inc. - Depositary Shares, Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock, Series A (BWBBP)